Form 4 Filing for NewGenIvf Group Ltd

On October 5, 2026, Wing Fung Alfred Siu, Chairman & CEO of NewGenIvf Group Ltd, acquired 139,811 Class B Ordinary Shares through the exercise of vested stock options. These options were granted under the Issuer's 2024 Share Incentive Plan and exercised via Option Agreements dated July 8, 2026, and August 17, 2026. The acquisition price was $0.0001 per share. Following this transaction, Mr. Siu beneficially owns 146,132 Class B Ordinary Shares. The reported share amounts have been adjusted to reflect two 1-for-3 reverse stock splits that occurred on July 6, 2026, and September 1, 2026. The filing also notes the disposal of 49,098 and 90,713 stock options, respectively, related to the underlying Class B Ordinary Shares.